A commonly used blood pressure drug could help fight cancer by opening up blood vessels in solid tumours.
Used beside conventional cancer-fighting drugs, it could improve life expectancy, experts believe.
Following successful testing in mice, doctors plan to give losartan to patients with pancreatic cancer to see if it can tackle this hard-to-treat disease, Nature Communications reports.
Currently, only 5% of pancreatic cancer patients survive for at least 5 years.
This is partly because only one in 10 people with the disease has a tumour that is operable.
Future hope Investigators at the Massachusetts General Hospital in the US are currently recruiting volunteer patients with inoperable pancreatic cancer to test out the new drug combination of chemotherapy plus losartan.....
Topic Locked
Posted - 02 Oct 2013 : 09:55:45
